Skip to main content
. 2013 Feb 12;70(4):274–282. doi: 10.1136/oemed-2012-101093

Table 1.

Crude and adjusted ORs and 95% CIs for congenital anomalies by exposure to TTHM levels (µg/l) during the first trimester of pregnancy

Total trihalomethane exposure (µg/l) Cases n (%) Controls n (%) Crude OR 95% CI Adjusted OR 95% CI
Heart anomalies
 Low (1.3 µg/l) 20 (35.1) 1325 (45.6) 1 1
 High (21.9 µg/l) 37 (64.9) 1578 (54.4) 1.55 0.89 to 2.69 1.54* 0.89 to 2.68
Musculoskeletal anomalies
 Low (1.3 µg/l) 19 (51.4) 1325 (45.6) 1 1
 High (21.9 µg/l) 18 (48.6) 1578 (54.4) 0.80 0.42 to 1.52 0.74† 0.39 to 1.42
Urogenital anomalies
 Low (1.3 µg/l) 5 (21.7) 1325 (45.6) 1 1
 High (21.9 µg/l) 18 (78.3) 1578 (54.4) 3.02 1.12 to 8.16 3.01‡ 1.11 to 8.16

High–Petrasiunai; Low–Other water supply zones.

*Adjusted for: age, body mass index, chronic disease, alcohol consumption and fetus number.

†Adjusted for: body mass index, fetus number, previous premature birth and infant sex.

‡Adjusted for: age, body mass index, chronic disease, previous premature birth and infant sex.